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A B S T R A C T
Three commercial samples consisting of enriched calcium-free caseinophosphopeptides (CPP), enriched calcium-
bound caseinophosphopeptides (Ca-CPP) and an enzymatically hydrolyzed casein (hCN) were in vitro digested
according to COST-Infogest protocol. As assessed by UPLC-HR-MS/MS, the digests contained 207–235 unique
caseinophosphopeptides, and the species presenting the cluster sssEE were more abundant in CPP digest. The
antioxidant activity at three diﬀerent doses of each digest was ﬁrstly evaluated on human intestinal Caco-2/HT-
29 70/30 co-culture. In presence of AAPH, hCN and CPP digests displayed a dose-dependent antioxidant activity
equal or even greater than Vitamin C. In presence of Fe2+, the digests exerted an antioxidant activity mainly at
the highest dose. Antioxidant activities of the intestinal metabolized digests was then evaluated on human
osteoblast (Saos-2) cells. The digests exerted an antioxidant activity in presence of AAPH, but not in presence of
Fe2+. These results highlight milk-derived peptides as potential dietary supplements for gut and bone health.
1. Introduction
The oxidative damage is at the base of aging-associated modiﬁca-
tions that together with a low grade inﬂammation can concur to chronic
diseases onset, high health expenditure and poor quality of life (Liguori
et al., 2018). These concerns boosted the research to exploit the po-
tential of food components with antioxidant properties as an alternative
therapy to drugs (Korhonen & Pihlanto, 2003). This approach emerges
as a new promising ﬁeld in human nutrition and, for this reason, at-
tracted interest for developing new dietary supplements. So far, three
diﬀerent antioxidant actions have been recognized: i) scavenging of
reactive oxygen species (ROS), or primary antioxidant mechanism,
which is based on a direct physical interaction between antioxidants
and free radicals; ii) metal chelation, or secondary antioxidant me-
chanism; iii) modulation of enzymes involved in ROS production and
destruction. The ROS are unstable radicals and non-radicals physiolo-
gically produced during cellular metabolism, and they play a role in cell
functions such as signaling, ion transportation and regulation of gene
expression (Lü, Lin, Yao, & Chen, 2010). Nonetheless, an excessive ROS
production promotes damage to cell macromolecules (DNA, proteins
and lipids) inducing an oxidative stress caused by direct interactions
between ROS and the same macromolecules.
Bovine caseinophosphopeptides are phosphorylated peptides en-
zymatically released from casein (CN) during cheese ripening (López-
Expósito, Amigo, & Recio, 2012) and/or from in vitro and in vivo en-
zymatic digestion (Boutrou et al., 2013; Phelan, Aherne-Bruce,
O’Sullivan, FitzGerald, & O’Brien, 2009). Caseinophosphopeptides are
capable to bind and carry divalent cations (Meisel, 1997), and this
feature has been related to chemical features such as length, level of
phosphorylation, negative net charge, distribution of phosphorylated
residues, and presence of the cluster Ser(P)-Ser(P)-Ser(P)-Glu-Glu
(sssEE) in their primary sequence (Ferraretto, Gravaghi, Fiorilli, &
Tettamanti, 2003; Gravaghi et al., 2007). The cation-binding activity of
caseinophosphopeptides has been demonstrated to have biological in-
terest, since it positively aﬀects calcium and iron availability
(Bouhallab & Bouglé, 2004) and scavenges free radicals (Kitts, 2005).
The antioxidant properties of caseinophosphopeptides have been only
studied in vitro using aqueous solution (Chiu & Kitts, 2003; Kitts, 2005),
oil-in-water emulsions (Díaz, Dunn, McClements, & Decker, 2003),
phosphatidylcholine liposomes (Kansci, Genot, Meynier, Gaucheron, &
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Chobert, 2004), and ground beef (Díaz & Decker, 2004). All these
studies have highlighted the caseinophosphopeptide ability to induce
free radical scavenging activity in addition to a Fenton reaction in-
hibition as a consequence of metal quenching.
García-Nebot, Cilla, Alegría, and Barberá (2011) demonstrated that
caseinophosphopeptides are capable to decrease the damage induced
by lipid peroxidation and to exert protective action against H2O2
treatment in Caco-2 cells. (Laparra, Alegría, Barberá, & Farré, 2008) did
not evidence this eﬀect, but an increase in the GSH-reductase and a
modulation of cell cycle phase activity have been detected. Milk-de-
rived peptides are also known for their anti-osteopenic activity through
the inhibition of bone oxidative damage, bone-resorbing cytokines in
ovariectomized rats (Mada et al., 2017), and the promotion of calcium
uptake and osteoblast diﬀerentiation (Donida et al., 2009).
The study of the biological eﬀectiveness of caseinophosphopeptides
implies to ascertain whether the antioxidant activity is retained after
gastrointestinal digestion. In this regard, using a Caco-2 cell line,
(Laparra et al., 2008) demonstrated that in vitro gastrointestinal di-
gestion of caseinophosphopeptides inﬂuenced their antioxidant poten-
tial due to the degradation or release of caseinophosphopeptides from
CN.
Based on these evidences and data reported in literature, in the
present study we aimed to evaluate the antioxidant properties of three
commercial samples consisting of: i) enzymatically hydrolyzed bovine
CN (hCN); ii) enriched preparation of calcium-free bovine case-
inophosphopeptides (CPP); iii) enriched preparation of calcium-bound
bovine caseinophosphopeptides (CaCPP). Ultra-Performance Liquid
Chromatography-High Resolution tandem Mass Spectrometry (UPLC-
HR-MS/MS) was adopted for identifying the caseinophosphopeptides
present in the samples after in vitro static simulated gastrointestinal
digestion (SGID) according to the COST-Infogest protocol (Brodkorb
et al., 2019). The antioxidant activity of digests was evaluated in vitro
using a co-culture of Caco-2/HT-29 human intestinal cells under oxi-
dative conditions represented by a ROS generator and Fe2+ ions. Then,
the antioxidant activity of the basolateral content of the intestinal cell
co-culture, mimicking the intestinal metabolizate, was assessed in vitro
on human osteoblast-like Saos-2 cells.
2. Materials and methods
Cell culture media and reagents for in vitro SGID and biological
assays were from Sigma-Aldrich (St. Louis, MO, USA), FBS was from
EuroClone (Pero, Italy). The eluents for UPLC were from Panreac
Química (Castellar del Vallès, Spain) and those for HR-MS/MS from
Thermo Fisher Scientiﬁc (San Jose, CA, USA) if not diversely speciﬁed.
2.1. Commercial samples
Three commercial powdered samples were considered. The hCN
sample represented an enzymatic hydrolyzate of bovine CN. CPP and
CaCPP samples were enriched preparations of calcium-free and cal-
cium-bound bovine caseinophosphopeptides, respectively. As reported
by the corresponding technical data sheets, the caseinophosphopeptide
contents (%, w/w) of hCN, CPP and CaCPP were 26, 90.5 and 95, re-
spectively. The calcium content (%, w/w) was 0.015 and 6.6 in CPP and
CaCPP, respectively. The calcium content was not reported for hCN.
2.2. In vitro static simulated gastrointestinal digestion (SGID)
To simulate the in vivo physiological digestive process, the static
protocol proposed by (Brodkorb et al., 2019) was used omitting the oral
phase. For each sample, 2.5 g of powder was resuspended in 2.5 mL of
MilliQ water. To inhibit enzyme activity, at the end of digestion 1mM
4-(2-aminoethyl)benzenesulfonylﬂuoride hydrochloride was added, the
samples were frozen in liquid nitrogen and stored at −80 °C. Subse-
quently, centrifugation at 4 °C (Eppendorf centrifuge 5810 R,
Eppendorf, Hamburg, Germany) was performed at 3100g for 20min to
separate the insoluble components. The osmolality of the digests was
measured using an osmometer (Micro Osmometer Type 6/6M, Löser
Messtechink, Berlin, Germany). If necessary, it was corrected to obtain
physiological values of 300mOsm/kg H2O. This step avoided osmotic
shocks to in vitro intestinal co-culture after administration of the digest.
To adjust osmolality, MilliQ water was added to samples with osmol-
ality greater than 300mOsm/kg H2O and mannitol (0.1143M) was
used for samples with lower values.
Three diﬀerent protein concentrations (2.4, 3.2, and 6.4 µg/µL) of
each in vitro digests were used.
2.3. Identiﬁcation of caseinophosphopeptides in digested samples
The identiﬁcation of caseinophosphopeptides was performed in
hCN, CPP and CaCPP digests after enrichment of phosphorylated pep-
tides using the High-SelectTM Fe-NTA Phosphopeptide Enrichment Kit
(Thermo Fisher Scientiﬁc) according the manufacturer’s indications.
The enriched fractions were vacuum–dried and kept at −24 °C. Before
chromatographic fractionation, samples were re-suspended in 50 µL of
0.1% (v/v) formic acid.
The caseinophosphopeptide-enriched fractions were separated on
an Acquity UPLC BEH300 C18 column (150× 2.1mm, 1.7 μm)
(Waters, Milford, MA, USA) using an Acquity UPLC module (Waters),
and the peptides were identiﬁed by HR-MS/MS on a Q Exactive hybrid
quadrupole-Orbitrap mass spectrometer (Thermo Fisher Scientiﬁc) as
described by (De Luca et al., 2016). The MS data were processed and
the caseinophosphopeptides were identiﬁed using the Proteome Dis-
coverer 1.4 software (Thermo Fisher Scientiﬁc). The MS and MS/MS
spectra were matched against the database of Bos taurus (UniProt taxon
ID 9913) CN considering their genetic variants (Farrell et al., 2004).
Settings were as follows: enzyme, No-Enzyme; mass accuracy window
for precursor ions, 5 ppm; mass accuracy window for fragment ions,
0.02 Da; no ﬁxed modiﬁcations; variable modiﬁcations: phosphoryla-
tion of serine and threonine, deamidation of asparagine and glutamine,
oxidation of methionine. The false discovery rate of peptide identiﬁ-
cation was set to FDR=0.01 (Strict).
2.4. Human in vitro cell models
As an in vitro model of human intestine, a 70% Caco-2/30% HT-29
co-culture was seeded on the porous membrane of transwell wells
(Millicell, Merck, Darmstadt, Germany). The co-culture was used at the
6th day of post conﬂuence, when it was composed of both mucus se-
creting cells and absorptive enterocytes in a proportion similar to the
human small intestine (Ferraretto et al., 2018). Moreover, it presented
the functional digestive and absorptive features of human small intes-
tine.
As an in vitro model of human osteoblasts, Saos-2 cells (Saos-2 HTB-
85, ATCC, LGC standards, Sesto San Giovanni, Italy) were grown and
subcultured by passaging weekly in 75 cm2 ﬂasks containing Iscove’s
Modiﬁed Dulbecco’s Medium (IMDM) supplemented with 10% FBS,
4mM L-Glutamine, 0.1mg/L streptomycin, 100,000 U/L penicillin,
0.25mg/L amphotericin-B in a humidiﬁed atmosphere of 5% CO2 at
37 °C (Donida et al., 2009).
2.5. In vitro digest metabolization by intestinal cells (IM digests)
To mimic in vitro the changes occurring at the intestinal cell level,
each digest (in 400 µL HBSS buﬀer) was administered in the apical
chamber of transwell wells (Millicell, Merck) where the 70% Caco-2/
30% HT-29 co-culture was seeded. After 2 h, the contents of the baso-
lateral chambers, named IM-hCN, IM-CPP and IM-CaCPP, were re-
covered and administered to Saos-2 cells.
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2.6. Cell viability assay (MTT)
Cell viability assay (MTT) allowed to evaluate cell proliferation and
viability on the basis of the mitochondrial metabolic activity (Riss,
Moravec, Niles, Duellman, Benink, Worzella, & Minor, 2004). Both the
co-culture and the Saos-2 cells were plated at 40,000 cells/cm2 in 24
multiwell plates and used at 80% of conﬂuence. The cell viability was
monitored in presence of the three digests alone or in combination with
either with 2,2′-azobis(2-methylpropionamide) dihydro-chloride
(AAPH), able to generate peroxyl radicals, or with FeCl2 (Fe2+) that can
induce the Fenton reaction. The same assay was repeated with the IM
digests. As a reference, the possible eﬀects of AAPH, Fe2+, the digestion
buﬀer (DB) and mannitol, at the diﬀerent doses added to the samples,
were studied. Cells were incubated with the samples for 2 h at 37 °C and
subsequently with MTT for 4 h to evaluate the formazan salt formation.
Results were expressed and reported as percentage vs control of non-
treated cells (CTR).
2.7. Cell-based antioxidant assay (CAA)
The cell-based antioxidant assay (CAA) measured the ROS produc-
tion in living cells by means of the ﬂuorescent probe 2′,7′-dichloro-
ﬂuorescin diacetate (DCFH-DA) (Wan, Liu, Yu, Sun, & Li, 2015). Both
co-culture and Saos-2 cells were plated at 40,000 cells/cm2 in a black
96-well plate (CELLSTAR, Greiner Bio-One, Kremsmünster, Austria) in
their complete medium. All the samples here considered, hCN, CPP,
CaCPP, IM-hCN, IM-CPP, IM-CaCPP, were administered alone or in
combination with 250 µM either AAPH or Fe2+ in HBSS buﬀer. In ad-
dition, the prooxidant activity of AAPH and iron, as well as the anti-
oxidant activity of 1mM Vitamin C (Vit C) were evaluated. The ﬂuor-
escence (λexcitation= 485; λemission= 538) was measured immediately
after sample administration and every 15min till 120min by a Wallac
Victor2 1420 Multilabel Counter plate reader (Perkin Elmer, Waltham,
MA, USA). All results were expressed as relative CAA units according to
(Hidalgo et al., 2018) after subtracting the DB value from the digest
readings. Positive CAA values indicated antioxidant activity vs CTR
(CAA value of 0, representing the basal oxidative status of the control of
non-treated cells), while negative CAA values indicated oxidant activity
vs CTR. Moreover, positive values signiﬁcantly diﬀerent from CTR were
also compared to Vit C eﬀect, whereas negative values signiﬁcantly
diﬀerent from CTR were also compared to AAPH or Fe2+ activities.
2.8. LDH release
The colorimetric assay was performed using the Cytotoxicity de-
tection kit (LDH, Roche Diagnostics, Mannheim, Germany). The assay
was based on the measurement of lactate dehydrogenase (LDH) activity
released into the medium from the cytosol of cells with a damaged
membrane. Both co-culture and Saos-2 cells were plated at 40,000
cells/cm2 in a 24-well plate (Greiner Bio-One) in their complete
medium. All the samples here considered (hCN, CPP, CaCPP, IM-hCN,
IM-CPP, IM-CaCPP) were administered alone or in combination with
250 µM either AAPH or Fe2+ in a complete HBSS solution. Results were
expressed as relative LDH release (% vs control of non-treated cells,
CTR) after subtracting the DB value from the digest readings.
2.9. Statistical analysis
Statistically signiﬁcant diﬀerences among digest or IM digest mean
values at the three diﬀerent doses were established by one-way ANOVA
followed by Bonferroni post hoc t-test with the SPSS 20 statistical
software (SPSS, Chicago, IL, USA). In the case of comparisons among
mean values and AAPH, Fe2+ or Vit C, an unpaired Student’s t-test with
two-tailed distribution has been performed. A P < 0.05 was considered
signiﬁcant, and it was represented by diﬀerent letters for digests or IM
digests at diﬀerent doses, or symbols for comparisons with positive and
negative oxidation controls.
3. Results
3.1. Qualitative proﬁle of caseinophosphopeptides in hCN, CPP and CaCPP
in vitro digests
After in vitro SGID, the UPLC-HR-MS/MS analysis of digests revealed
for hCN, CPP and CaCPP the qualitative proﬁles of caseinopho-
sphopeptides summarized in Table 1.
In detail, about the same number of unique caseinophosphopeptides
were present in hCN, CPP and CaCPP digests. In all samples 26–35%
and 60–62% of total peptides were smaller than 1 kDa and in the MW
range of 1–2 kDa, respectively. Monophosphorylated caseinopho-
sphopeptides accounted for most of the identiﬁed species, followed by
di- and tri-phosphorylated forms. In the hCN and CaCPP digests, the
ratio among mono-, di- and tri-phosphorylated peptides was almost the
same. Contrarily, a quite similar proportion of the diﬀerently phos-
phorylated forms was recorded for the CPP digest. The peptides con-
taining the cluster sssEE represented 6%, 17% and 9% of total peptides
found in hCN, CPP and CaCPP, respectively. In general, they were
shorter forms of the cluster-containing peptides αS2-CN f(53–70), β-CN f
(1–25) and β-CN f(2–25). The peptide β-CN f(1–25)3P was identiﬁed
only in the digest of CaCPP, whereas 4, 11 and 6 shorter forms (8–19
amino acids long) of the β-CN f(1–25) peptide presenting 3 to 5 phos-
phorylations were detected in the hCN, CPP and CaCPP digests (data
not shown). Overall, the digests shared forty caseinophosphopeptides
(Table 2).
3.2. Cell viability of the 70% Caco-2/30% HT-29 co-culture and Saos-2
cells after digest and IM digest administration
After in vitro SGID, the hCN, CPP and CaCPP digests were ad-
ministered to the 70% Caco-2/30% HT-29 co-culture to mimic in vitro
interactions at the intestinal epithelium. Digest administration per se
did not signiﬁcantly aﬀect intestinal cell viability. In presence of AAPH
or Fe2+, only in the case of CPP and CaCPP digests administration some
slight but signiﬁcant (P < 0.05) decrements in cellular viability were
observed (Fig. 1A, B, C). These very small entity decrements, about
10–20% vs. control of non-treated cells, CTR, are presumably due to
little variations in the number of living cells in each well, without
consequences on the cell morphology and functions.
Successively, the IM-hCN, IM-CPP and IM-CaCPP samples were
administered to Saos-2 cells. Similarly, the administration of IM digests,
alone or in combination with AAPH or Fe2+, did not modify the Saos-2
cell viability (Fig. 1D, E, F). In addition, DB, mannitol, AAPH and Fe2+
were individually assayed for cell viability without revealing any sig-
niﬁcant (P < 0.05) eﬀect (Supplementary Fig).
Table 1
Qualitative proﬁle of caseinophosphopeptides revealed in hCN, CPP and CaCPP
digests. (n, number of unique caseinophosphopeptides; sssEE, number of case-
inophosphopeptides containing the cluster sssEE; 1P/2P/3P, mono-, di- and tri-
phosphorylated, precursor CNs, and molecular weight (MW) as a percentage
(%) of total peptides).
hCN CPP CaCPP
n 207 235 220
sssEE (n) 12 41 19
1P/2P/3P (%) 63/23/12 39/30/22 62/23/9
αS1-CN/αS2-CN/β-CN (%) 37/31/19 37/38/21 34/26/26
MW < 2 kDa (%) 96 91 88
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3.3. Antioxidant activity of in vitro digests on 70% Caco-2/30% HT-29 co-
culture
The digested samples alone did not exert any signiﬁcant (P < 0.05)
prooxidant action on the 70% Caco-2/30% HT-29 co-culture (data not
shown). This ﬁnding conﬁrmed previous results of García-Nebot et al.
(2011), who tested in vitro tryptic digests of bovine CN on Caco-2 cells.
When combined with AAPH, digested hCN administered to cells at
6.4 µg/µL induced an antioxidant eﬀect 2.6 times higher than Vit C
(Fig. 2A). CPP digest acted as an antioxidant till 3.3 times higher than
Vit C, with a dose-dependent behavior (Fig. 2B). Finally, the CaCPP
sample showed no signiﬁcant (P < 0.05) eﬀects (Fig. 2C).
Digests administered to the co-culture in presence of Fe2+ induced
prooxidant or antioxidant eﬀects. In detail, hCN was more oxidant than
Fe2+ at 2.4 and 3.2 µg/µL doses, whereas at 6.4 µg/µL it exerted an
antioxidant activity 4.4 times higher than Vit C (Fig. 2D). The admin-
istration of CPP digest along with Fe2+ increased the cell oxidative
status at the lowest dose, but it behaved as antioxidant at higher doses,
thus resulting 3.5 and 3.7 times more eﬀective than Vit C (Fig. 2E). The
administration of CaCPP digest and Fe2+ displayed a prooxidant eﬀects
at the minor and intermediate doses, while the antioxidant activity of
the highest dose was 1.5 times higher than Vit C (Fig. 2F).
3.4. Antioxidant activity of IM digests on Saos-2 cells
The administration of IM-hCN, IM-CPP and IM-CaCPP did not cause
any signiﬁcant (P < 0.05) modiﬁcation of the basal cell oxidative
status of Saos-2 cells (data not shown). The combination of the three IM
digests with AAPH resulted in a dose-dependent antioxidant activity,
although some diﬀerences among the samples were observed. Indeed,
IM-hCN, IM-CPP and IM-CaCPP showed antioxidant eﬀects 3.2–4.9,
2.4–5.3 and 1.2–4.6 times higher than that of Vit C, respectively
(Fig. 3). In presence of Fe2+, IM-hCN displayed an antioxidant activity
only at the minor dose, and 2 times higher than Vit C (Fig. 3D). How-
ever, IM-CPP and IM-CaCPP did not induce any signiﬁcant (P < 0.05)
eﬀects (Fig. 3E and F).
3.5. LDH release by 70% Caco-2/30% HT-29 co-culture and Saos-2 cells
after administration of digests or IM digests
Digest administration in presence of Fe2+ did not induce membrane
damage of the intestinal cells (Fig. 4A, B, C, white bars). In presence of
AAPH, all digests showed a dose-dependent protective eﬀect compared
to AAPH administration alone (P < 0.05). Similarly, the administra-
tion of IM digest, in combination with Fe2+ or AAPH, did not aﬀect the
membrane integrity of Saos-2 cells (Fig. 4D, E, F). All IM digests showed
a signiﬁcant (P < 0.05) protective eﬀect vs AAPH at the highest dose,
and, only in the case of IM-hCN, even at the intermediate dose.
4. Discussion
In the present study, we investigated three commercial samples,
Table 2
Common caseinophosphopeptides among hCN, CPP and CaCPP digests. Some of them were previously reported in literature as released in vivo after CN or milk
ingestion (references are indicated in the parentheses). (S) indicates phosphoserine; (S, T) indicates phosphorylation at both, Ser and Thr, residues.
Casein Fragment Sequence Phosphorylation Reference
αS1-CN 35–42 EKVNELsK 1 (S) Barbé et al. (2014)
αS1-CN 37–42 VNELsK 1 (S)
αS1-CN 43–47 DIGsE 1 (S) Sanchón et al. (2018)
αS1-CN 43–53 DIGsEStEDQA 2 (S,T)
αS1-CN 43–53 DIGsESTEDQA 1 (S) Sanchón et al. (2018)
αS1-CN 43–54 DIGsEStEDQAM 2 (S,T)
αS1-CN 43–58 DIGsEsTEDQAMEDIK 2 (S) Barbé et al. (2014)
αS1-CN 44–52 IGSEstEDQ 2 (S,T) Sanchón et al. (2018)
αS1-CN 59–65 QMEAEsI 1 (S)
αS1-CN 109–118 LEIVPNsAEE 1 (S) Boutrou et al. (2013); Sanchón et al. (2018)
αS1-CN 109–119 LEIVPNsAEER 1 (S) Barbé et al. (2014); Boutrou et al. (2013)
αS1-CN 110–118 EIVPNsAEE 1 (S) Sanchón et al. (2018)
αS1-CN 110–119 EIVPNsAEER 1 (S) Barbé et al. (2014); Boutrou et al. (2013); Sanchón et al. (2018)
αS1-CN 111–119 IVPNsAEER 1 (S) Barbé et al. (2014)
αS2-CN 7–17 VsssEESIIsQ 4 (S)
αS2-CN 13–17 SIIsQ 1 (S)
αS2-CN 13–18 SIIsQE 1 (S)
αS2-CN 13–19 SIIsQET 1 (S)
αS2-CN 14–17 IIsQ 1 (S)
αS2-CN 126–136 EQLstsEENSK 3 (2S, T)
αS2-CN 126–136 EQLStsEENSK 2 (S,T)
αS2-CN 129–136 sTsEENSK 2 (S)
αS2-CN 138–146 TVDMEStEV 1 (T) Boutrou et al. (2013)
αS2-CN 138–146 TVDMEsTEV 1 (S) Boutrou et al. (2013)
αS2-CN 139–146 VDMEStEV 1 (S)
β-CN 6–16 LNVPGEIVEsL 1 (S) Barbé et al. (2014); Sanchón et al. (2018)
β-CN 7–16 NVPGEIVEsL 1 (S) Sanchón et al. (2018)
β-CN 7–17 NVPGEIVEsLs 2 (S) Chabance et al. (1998)
β-CN 8–16 VPGEIVEsL 1 (S) Sanchón et al. (2018)
β-CN 11–16 EIVEsL 1 (S)
β-CN 12–16 IVEsL 1 (S)
β-CN 32–38 KFQsEEQ 1 (S)
β-CN 33–37 FQsEE 1 (S)
β-CN 33–38 FQsEEQ 1 (S)
β-CN 33–39 FQsEEQQ 1 (S)
β-CN 33–40 FQsEEQQQ 1 (S)
β-CN 34–39 QsEEQQ 1 (S)
β-CN 163–167 LSLsQ 1 (S)
κ-CN 122–131 INTIAsGEPT 1 (S)
κ-CN 124–131 TIAsGEPT 1 (S)
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bovine hCN, CPP and CaCPP, as potential antioxidant dietary supple-
ments. To simulate the in vivo physiological digestive process, the in
vitro SGID according to the internationally-approved COST-Infogest
digestion protocol (Brodkorb et al., 2019) was performed. All digests
were characterized for their qualitative proﬁle of caseinopho-
sphopetides. Similar number of caseinophosphopetides was revealed in
all of them. Despite this, tri-phosphorylated forms and cluster sssEE
containing peptides were most abundant in CPP digest. The cluster
sssEE represents the sequences αS1-CN f(66–70), αS2-CN f(8–12), αS2-
CN f(56–60) and β-CN f(17–21) of the native bovine CNs (Farrell et al.,
2004), and it is well characterized as conferring a strong cation-binding
activity to caseinophosphopeptides. The latter, in turn, have been de-
monstrated to have biological interest for positive eﬀects on calcium
and iron availability (Bouhallab & Bouglé, 2004) and free radical
scavenging (Kitts, 2005). Indeed, some of the caseinophosphopeptides
in common among the three digests were previously revealed in dif-
ferent in vitro and in vivo (Table 2) studies. Recently, (Sanchón et al.,
2018) reported the caseinophosphopeptides released from the αS1-CN f
(43–53) region after in vitro or in vivo CN digestion. Some of these
peptides were found in the hCN, CPP and CaCPP digests (Table 2). The
same authors also showed that the peptides originated in vivo from the
N-terminal region of β-CN were shorter in length compared to those
obtained in vitro. This feature also applied to N-terminal β-CN peptides
revealed in hCN, CPP and CaCPP digests, which however contained
some peptides identical to those released in vivo (Sanchón et al., 2018).
Research studies of García-Nebot and collaborators (García-Nebot et al.,
2011; García-Nebot, Alegría, Barberá, Contreras, & Recio, 2010; García-
Nebot, Alegría, Barberá, Gaboriau, & Bouhallab, 2015) also reported
identical peptides after in vitro digestion [αS2-CN f(138–146)1P, β-CN f
(6–16)1P, β-CN f(7–16)1P, β-CN f(11–16)1P, β-CN f(33–39)1P and β-
CN f(33–40)1P].
The capability of caseinophosphopeptides to chelate metal ions
mainly accounts for their secondary antioxidant activity (Kitts, 2005),
and in this regard the key role in chelation is exerted by the sssEE
cluster (Miquel, Alegría, Barberá, & Farré, 2006). The formation of iron-
phosphopeptide complexes by peptides carrying the sssEE cluster oc-
curs at a certain Fe2+ to Ser(P) molar ratio (Kitts, 2005). Overall, the
binding of phosphopeptides with Fe2+ could produce stable iron-
phosphopeptide complexes, and this phenomenon is the basis for re-
duction of ROS formation through the Fenton reaction. In literature,
little information is available regarding the antioxidant activity of
speciﬁc caseinophosphopeptides. As a matter of fact, only the cluster-
containing peptide β-CN f(1–25)4P has been extensively studied
(Bouhallab et al., 2002; Kibangou et al., 2005). The peptide β-CN f
(1–25)3P was identiﬁed only in the digest of CaCPP, while shorter and/
or diﬀerent phosphorylated forms of β-CN f(1–25), still containing the
cluster and detected in our digests. Based on this, it could be hy-
pothesized all these peptides could also elicit antioxidant properties
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similar to β-CN f(1–25)4P.
The antioxidant activity was tested using three diﬀerent doses of the
digests to evaluate a possible dose-eﬀect relationship. Firstly, we in-
vestigated the prooxidant or antioxidant eﬀects of digests on intestinal
cells. Indeed, some dietary components, including iron, can directly
interact with enterocytes by increasing their oxidative stress (Seril
et al., 2002). In presence of AAPH, hCN and CPP digests displayed a
primary dose-dependent antioxidant activity, sometimes more pro-
nounced than Vit C and likely due to scavenging of free radicals
(Fig. 2A, B and C). Instead, the CaCPP digest displayed a minor primary
antioxidant activity, which did not signiﬁcantly modify the basal oxi-
dative status of intestinal cells. This diﬀerent behavior was likely re-
lated to calcium preloading. The complexes between calcium ions and
caseinophosphopeptides in CaCPP were demonstrated to be particularly
stable (Perego et al., 2015). This feature likely impaired phosphopep-
tide interaction with ROS, thus reducing the primary antioxidant ac-
tivity of CaCPP (Kitts, 2005).
In presence of Fe2+, which promotes ROS production through the
Fenton reaction, the activity of digests appeared more heterogeneous
and dose-dependent (Fig. 2C, D and E). At the minor doses they be-
haved as prooxidants in a way comparable or higher than Fe2+, while
at the maximum tested dose they acted as antioxidants as much or more
than Vit C. The prooxidant action revealed at the lowest digest doses is
in accordance with the same activity displayed by both, a preparation
of enriched caseinophosphopeptides (Díaz & Decker, 2004) and known
Fe2+ chelators such as EDTA (Frankel, Satué-Gracia, Meyer, & German,
2002). As stated above, the formation of phosphopeptides/Fe2+ com-
plexes occurs at a precise Fe2+ to Ser(P) molar ratio (Kitts, 2005). This
might explain the dose-dependent secondary antioxidant activity of the
studied digests. Indeed, in literature prooxidant action has been de-
tected when the iron level stoichiometrically exceeded that of mole-
cules with chelating capability (Díaz & Decker, 2004). This condition
likely occurred when the lowest doses of the studied digests were
tested. It has to be mentioned that the Fe2+ amount (250 µM) employed
in the present work to mimic an oxidative stress, and capable to trigger
the Fenton reaction, hardly occurs in vivo. Anyway, at the highest doses
the opposite eﬀect was recorded (Fig. 2), and a LDH release, indicating
the damaged plasma membrane upon oxidative stress was not evi-
denced for all the tested doses.
The secondary antioxidant activity of CPP digest, unlike the two
other samples, was already evident at the intermediate dose. This
ﬁnding could be explained considering that CPP digest has the highest
number of caseinophosphopeptides carrying the sssEE cluster, as well as
the highest number of peptides with three or more phosphorylation
sites (Table 1). Moreover, CPP digest comprised the highest number of
caseinophosphopeptide sequences from αS1-CN and αS2-CN (Table 1),
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compared to hCN and CaCPP. In this regard, cluster-containing peptides
from αS1-CN have been reported to strongly chelate Fe2+ and, conse-
quently, to reduce the bioavailability of this metal (Bouhallab et al.,
2002; Kibangou et al., 2005). All together these features make CPP
digest more capable to bind and retain Fe2+, a property already de-
scribed for caseinophosphopeptides originated from αS-CN (Bouhallab
& Bouglé, 2004). In the case of CaCPP digest, it can be speculated that
almost all Ser(P) residues of caseinophosphopeptides were bound to
calcium ions. Therefore, an antioxidant activity based on Fe2+ binding
was detectable only at the major dose, when free Ser(P) likely overcame
the number of Fe2+ ions. This explanation is in agreement with the
suggested saturation mechanism proposed by (Rival, Boeriu, & Wichers,
2001), who negatively correlated caseinophosphopeptide chelating
properties with increasing Fe2+ concentrations. Analogously, the most
important prooxidant eﬀect was exerted by hCN, which contained the
lowest amount of caseinophosphopeptides and the highest proportion
of mono- and di-phosphorylated peptides. This likely accounted for its
minor capacity to bind Fe2+, especially at the minor doses.
To take into account the in vitro changes occurring at the intestinal
cell level, the IM digests were administered in vitro to Saos-2 cells. In
presence of AAPH, these digests exerted an antioxidant activity higher
than that of Vit C. On the contrary, the secondary antioxidant activity
(i.e. Fe2+ chelation) was retained only by the IM-hCN digest when
administered at the lowest dose. As far as the LDH release is concerned,
the administration of IM digest, in combination with Fe2+ or AAPH, did
not aﬀect the membrane integrity of Saos-2 cells (Fig. 4D, E, F). At the
highest dose, all IM digests showed a signiﬁcant protective eﬀect vs
AAPH, and even at the intermediate dose in the case of IM-hCN and IM-
CPP. Interestingly, digest and IM digest from hCN showed the highest
secondary antioxidant activity, probably due to the presence of peptides
other than caseinophosphopeptides. The possibility for CN-derived
peptides to reach bone and equally exert an antioxidant activity is far to
be unlikely (Chabance et al., 1998). Unfortunately, it was not possible
to determine by HR-MS/MS the (caseinophospho)peptidic proﬁle of the
IM digests due to the very low amount and negligible concentration of
peptides of available (basolateral) samples. Nonetheless, the obtained
results suggest metabolization and transport at in vitro intestinal epi-
thelium to modify the bioactivity of the initial digests administered to
the intestinal co-culture. Anyway, the antioxidant activity exerted by
the IM digests at the osteoblast level is worth of noting. Indeed, the
usefulness to ingest antioxidants is based on experimental evidences
that ROS are signaling molecules in the regulation of bone metabolism,
since the oxidative stress caused by the production of superoxide by
osteoclast leads to bone resorption (Rajput, Wairkar, & Gaud, 2018).
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5. Conclusions
The results here presented showed that CN hydrolysate and case-
inophosphopetide preparations submitted to SGID exerted primary and
secondary antioxidant properties at in vitro intestinal level in presence
of AAPH and Fe2+. Moreover, an antioxidant activity in presence of
AAPH was revealed for IM digests in cell model of human osteoblasts,
Saos-2 cells. Overall, these results claim the possibility to consider both
caseinophosphopeptide-enriched preparations and CN hydrolyzates as
potential tools for delivering milk-derived antioxidants addressed to
support in vivo gut and bone health.
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